PACIRA BIOSCIENCES, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
PACIRA BIOSCIENCES, INC. (PCRX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $9.97 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-04
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.97M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.74M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.53M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.38M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $9.97M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $6.74M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $7.53M 10-K · filed 2026-02-26 |
| 2025-09-30 | $8.38M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.25M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $10.12M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.49M 10-K · filed 2025-02-27 |
| 2024-09-30 | $11.75M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $12.77M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $13.86M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $14.96M 10-K · filed 2024-02-29 |
| 2023-09-30 | $16.10M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $17.66M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $18.63M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $19.86M 10-K · filed 2023-02-28 |
| 2022-09-30 | $20.54M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $21.85M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $23.19M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $24.55M 10-K · filed 2022-02-28 |
| 2021-09-30 | $24.39M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $25.64M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $27.06M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $28.25M 10-K · filed 2021-03-01 |
| 2020-09-30 | $29.52M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $30.91M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.16M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $19.46M 10-K · filed 2020-02-21 |
| 2019-09-30 | $19.45M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $20.28M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $10.71M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |